Loading...
Dear Readers,
On behalf of the editorial board, I am pleased to introduce the NEJM Journal Watch Neurology Top Stories of 2022. In the past year, we have seen practice-changing advances in the treatment of acute stroke, epilepsy, and spinal muscular atrophy; new practice guidelines for symptomatic Alzheimer dementia; and improvement in our ability to predict clinical outcomes of neurological diseases. Thank you for your continued interest, particularly as we transition fully to online content. All of us at NEJM Journal Watch Neurology wish you and yours a safe, healthy, and happy 2023!
In chronologic order, the NEJM Journal Watch Neurology Top Stories of 2022 are:
Enzyme-Inducing Anticonvulsants: Long-Term Cardiovascular Risk